Market Overview

Diagnostics Product and Service Provider MedTest Dx Unveils New Corporate Name Reinforcing Its Integrated Model that Better Serves Customers


Company Growth Reflects Its Seamless Integration of Multiple
Established Diagnostics Brands Known for Quality, Customer Service and

—Learn More About How MedTest Dx's Integrated Offerings Can
Advance Your
Clinical Laboratory Testing at AACC 2018
Booth #4516—

MedTest Holdings, the solution provider of choice offering integrated
products and services for decentralized clinical diagnostic testing,
today announced the debut of its new corporate name—MedTest Dx—at the
upcoming 2018 American Association for Clinical Chemistry (AACC) Annual
Scientific Meeting in Chicago, IL. MedTest Dx is a rapidly growing
company that is uniquely positioned to service the decentralized testing
community through its comprehensive portfolio of diagnostic products and
services that seamlessly integrates screening instruments, reagent
development and manufacturing, toxicology confirmation products and
world-class service.

To meet the specialized scientific and regulatory needs of its varied
customers, MedTest Dx has assembled and combined four respected
brands--globally-recognized reagent provider Pointe Scientific; the
Medical Laboratories Solutions (MLS) service organization known for
customer advocacy and excellence in chemistry, toxicology, and
hematology support; MedTest Dx's reliable, scalable, state-of-the-art
laboratory instrumentation; and Clinitox Diagostix's capabilities in
drugs of abuse screening and confirmation. Through its multiple
locations in Canton, MI; Fletcher, NC and Mississauga, Canada, MedTest
Dx delivers a large, diversified portfolio of customizable, quality
diagnostic products and services designed to enhance the clinical
laboratory testing of its diverse customer base, with the goal of
helping them grow their business and achieve their laboratory's full

Wayne Brinster, Chief Executive Officer of MedTest Dx, commented, "Our
goal in integrating these leading diagnostic brands to create MedTest Dx
was to offer a comprehensive high-quality solution that enables our
clinical lab customers to provide decentralized clinical testing
services efficiently and cost-effectively. We are proud of the breadth
and excellence of our integrated mix of products and services and of the
customer focus that informs everything we do. We are excited to
introduce our new company name at the AACC meeting and look forward to
welcoming returning and new customers and friends to Booth #4516. Come
and learn more about the many ways that MedTest Dx can strengthen your
clinical laboratory testing."

MedTest Dx's quality standards include FDA registration, 510(k) approval
and CLIA classification, ISO 13485, GMP, USDA annual inspection for
TRACES database, CMDCS, and CE Certification and Declaration of

The company that in now MedTest Dx began with the 2011 purchase of
Polymedco's chemistry product line. The addition of Pointe Scientific
brought high quality reagents, calibrators and controls, enzyme
immunoassays and specialty assays to the new firm. The acquisition of
Clinitox Diagostix added capabilities in drugs of abuse testing,
enabling confirmation tests via LC/MS instrumentation, reagents and
consumables. By acquiring Medical Laboratories Solutions (MLS), MedTest
Dx gained a highly regarded clinical diagnostic laboratory service
offering to complement and support the company's instruments, assays and

To learn more about how MedTest Dx's integrated solutions can strengthen
and support clinical laboratory services, visit AACC 2018 Booth #4516.

About MedTest Dx

MedTest Dx is purpose built to be the Solution Provider of Choice
for decentralized clinical testing. We offer a unique combination of
screening instruments, reagent manufacturing, world-class service
capabilities and full LC/MS toxicology confirmation products. We are a
globally-recognized reagent manufacturing organization meeting
scientific and regulatory needs as well as a service organization with
an impeccable reputation in chemistry, toxicology and hematology.
Working within laboratories' budgetary constraints, we can customize
reliable, scalable, state-of-the-art, low-cost testing solutions that
best meet the needs of all our customers. We challenge ourselves every
day with the question - "What Would our Customers Want?" Through this
relentless customer advocacy, we strive to deliver the best solutions to
customers' daily challenges. For more information, visit

View Comments and Join the Discussion!